STP1272

    A 3-Year Prospective Study of Serum Titanium Levels in Patients with Primary Total Hip Replacements

    Published: Jan 1996


      Format Pages Price  
    PDF Version (144K) 9 $25   ADD TO CART
    Complete Source PDF (9.2M) 9 $87   ADD TO CART


    Abstract

    Serum titanium concentration was measured in subjects undergoing primary total hip replacement (THR) using a prospective, controlled, longitudinal study design. One group of subjects underwent “hybrid” THR utilizing a commercially pure titanium (cp Ti) acetabular component inserted without bone cement and a modular cobalt-base alloy femoral component inserted with bone cement. A second group underwent cementless primary THR utilizing a titanium-6% aluminum-4% vanadium modular femoral component and a cp Ti acetabular component. A third group of subjects consisted of contemporaneous age and sex matched controls without implants or systemic disease. Serum titanium levels are elevated at all intervals up to 3 years postoperative in patients with cementless titanium alloy THR with respect to the baseline preoperative concentration and with respect to controls without implants. The “hybrid” THRs also demonstrate serum titanium elevations with respect to controls. At this juncture, we have observed no correlation between serum titanium levels and clinical function, nor have we identified any toxic effects.

    Keywords:

    ion release, titanium, total hip replacement


    Author Information:

    Jacobs, JJ
    Associate Professor, Scientist, Research Nurse, Associate Professor and Professor and Director of the Rush Arthritis and Orthopedics Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il

    Skipor, AK
    Associate Professor, Scientist, Research Nurse, Associate Professor and Professor and Director of the Rush Arthritis and Orthopedics Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il

    Black, J
    Principal, IMN Biomaterials, King of Prussia, PA

    Patterson, LM
    Associate Professor, Scientist, Research Nurse, Associate Professor and Professor and Director of the Rush Arthritis and Orthopedics Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il

    Paprosky, WP
    Associate Professor, Scientist, Research Nurse, Associate Professor and Professor and Director of the Rush Arthritis and Orthopedics Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il

    Galante, JO
    Associate Professor, Scientist, Research Nurse, Associate Professor and Professor and Director of the Rush Arthritis and Orthopedics Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il


    Paper ID: STP16094S

    Committee/Subcommittee: F04.18

    DOI: 10.1520/STP16094S


    CrossRef ASTM International is a member of CrossRef.